Acarbose
Acarbose is a pharmaceutical drug with 58 clinical trials. Historical success rate of 81.8%.
Success Metrics
Based on 36 completed trials
Phase Distribution
Phase Distribution
3
Early Stage
6
Mid Stage
41
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
81.8%
36 of 44 finished
18.2%
8 ended early
0
trials recruiting
58
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Multicenter, Randomized, Open-Label, Parallel-Controlled Clinical Study Comparing the Efficacy and Safety of Cofrogliptin Versus Acarbose in Drug-Naïve Patients With Type 2 Diabetes
Study of Acarbose in Longevity
A Study to Assess the Efficacy and Safety of ASP1941 in Asian Subjects With Type 2 Diabetes Mellitus
Acarbose and Prandial Insulin for the Treatment of Gestational Diabetes Mellitus.
Human Oral Detection of Glucose Olygomers
Clinical Trials (58)
A Multicenter, Randomized, Open-Label, Parallel-Controlled Clinical Study Comparing the Efficacy and Safety of Cofrogliptin Versus Acarbose in Drug-Naïve Patients With Type 2 Diabetes
Study of Acarbose in Longevity
A Study to Assess the Efficacy and Safety of ASP1941 in Asian Subjects With Type 2 Diabetes Mellitus
Acarbose and Prandial Insulin for the Treatment of Gestational Diabetes Mellitus.
Human Oral Detection of Glucose Olygomers
Effect of Acarbose and Mixture of Pioglitazone and Metformin in Patients With Type 2 Diabetes
Research of Intensive Lifestyle Intervention for PCOS Patients With IGT
Real-world Study Comparing the Adherence and Effectiveness of Linagliptin vs. Acarbose
Efficacy and Safety of Alogliptin vs. Acarbose in Chinese Type 2 Diabetes Mellitus (T2DM) Patients With High CV Risk or CHD Treated With Aspirin and Inadequately Controlled With Metformin Monotherapy or Drug Naive
Comparison of Two Treatment Regimens in Patients With Type 2 Diabetes After Short-term Intensive Insulin Therapy
Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose)
Role of Insulin Action and Free Fatty Acids in Hyperandrogenism of Women With Polycystic Ovary Syndrome
A Phase IV Study in Drug-Naive Patients With T2DM in China
Acarbose and Older Adults With Postprandial Hypotension
Evaluating Exenatide for the Treatment of Postprandial Hyperinsulinemic Hypoglycemia
Study to Evaluate the Efficacy of Acarbose,Metformin,Sitagliptin Combination Treatment in DM Patients
Loose-dose Combination of Acarbose and Metformin for T2DM in Metformin-failure Patients
Remission Evaluation of Metabolic Interventions in Type 2 Diabetes (REMIT Pilot Trial)
Delineation of the Role of Glucagon-like Peptide-1 Signalling in Relation to Increased Carbohydrate Content in the Distal Small Intestines
A Comparison of Two Treatment Strategies in Older Participants With Type 2 Diabetes Mellitus (T2DM)
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 58